Literature DB >> 2959901

Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of MDI with a spacer device.

J Mallol1, L Barrueto, G Girardi, O Toro.   

Abstract

Twenty-eight infants admitted to Exequiel González Cortes Children's Hospital because of acute wheezing (AW) were randomly assigned to three study groups. Fenoterol (FNT), ipratropium bromide (IB), and placebo were administered respectively to children in the different groups by means of metered dose inhalers (MDI) with spacers, using doses of 3 puffs every hour, for 4 hours. The degree of bronchial obstruction was assessed clinically and scored with the single-blind method every hour prior to each treatment. The criterion of a bronchodilator effect was a significant decrease in the degree of bronchial obstruction at subsequent scorings. The scores of the three groups were compared using the Student's t test for matched samples. The same test was also applied to the independent samples for determining the superiority of one treatment, FNT or IB, over the other. The results indicated a significant decrease in the scores of the groups receiving FNT and IB (P less than 0.05); this did not occur in the group in which placebo was used. FNT produced a more rapid and sustained effect than IB (P less than 0.05). Significant bronchodilator effect was obtained in infants with AW when repeated doses of FNT or IB were administered with MDI and spacers. This effect was significantly greater in the group treated with FNT.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959901     DOI: 10.1002/ppul.1950030511

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  9 in total

1.  Drug delivery from holding chambers with attached facemask.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

2.  A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease.

Authors:  R Kraemer; P Birrer; K Modelska; C C Aebischer; M H Schöni
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

3.  A non-electrostatic spacer for aerosol delivery.

Authors:  H Bisgaard; J Anhøj; B Klug; E Berg
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

Review 4.  Classification and treatment of pneumonia.

Authors:  R Bahl; N Bhandari; M K Bhan
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

5.  Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness.

Authors:  J R Clarke; H Aston; M Silverman
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

Review 6.  Systematic review of instruments aimed at evaluating the severity of bronchiolitis.

Authors:  Carlos E Rodriguez-Martinez; Monica P Sossa-Briceño; Gustavo Nino
Journal:  Paediatr Respir Rev       Date:  2017-02-15       Impact factor: 2.726

Review 7.  The role of anticholinergic antimuscarinic bronchodilator therapy in children.

Authors:  M Silverman
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 8.  Anticholinergic drugs for wheeze in children under the age of two years.

Authors:  M L Everard; A Bara; M Kurian; T M Elliott; F Ducharme; V Mayowe
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

9.  Ipratropium bromide for symptomatic preterm infants.

Authors:  B Yuksel; A Greenough
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.